Progressive systemic sclerosis-from the molecular background to innovative therapies

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 2, 2010, Pages 521-525

  Szodoray, Peter ^a   Kiss, Emese ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

Author keywords

Pathogenesis; Review; Systemic sclerosis; Therapeutical possibilities

Indexed keywords

DIFFUSE SCLERODERMA; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METHODOLOGY; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; REVIEW; STEM CELL TRANSPLANTATION;

HUMANS; IMMUNOMODULATION; PHOTOCHEMOTHERAPY; SCLERODERMA, DIFFUSE; STEM CELL TRANSPLANTATION;

EID: 77954517657     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e110     Document Type: Review

References (33)

1. R. Sgonc, M. S. Gruschwitz, G. Boeck, N. Sepp, J. Gruber and G. Wick: Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 43, 2550-2562 (2000)
2. R. Sgonc, M. S. Gruschwitz, H. Dietrich, H. Recheis, M. E. Gershwin and G. Wick: Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98, 785-792 (1996) (Pubitemid 26349184)
3. A. Kalogerou, E. Gelou, S. Mountantonakis, L. Settas, E. Zafiriou and L. Sakkas: Early T-cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 64, 1233-1235 (2005) (Pubitemid 41113366)
4. J. Varga: Systemic sclerosis: an update. Bull NYU Hosp Jt Dis 66, 198-202 (2008)
5. T. A. Wynn: Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199-210 (2008) (Pubitemid 351160157)
6. A. E. Postlethwaite, H. Shigemitsu and S. Kanangat: Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 16, 733-8 (2004) (Pubitemid 39425547)
7. M. E. Nimni: The molecular organization of collagen and its role in determining the biophysical properties of the connective tissues. Biorheology 17, 51-82 (1980) (Pubitemid 10051163)
8. B. R. Olsen. Collagen biosynthesis. In: E. D. Hay (ed). Cell biology of extracellular matrix. New York, Plenum Press, 139-77 (1981)
9. A. J. van der Slot, A. M. Zuurmond, A. F. Bardoel, C. Wijmenga, H. E. Pruijs, D. O. Sillence, J. Brinckmann, D. J. Abraham, C. M. Black, N. Verzijl, J. DeGroot, R. Hanemaaijer, J. M. TeKoppele, T. W. Huizinga and R. A. Bank: Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 278, 40967-72 (2003) (Pubitemid 37280918)
10. A. Milano, S. A. Pendergrass, J. L. Sargent, L. K. George, T. H. McCalmont, M. K. Connolly and M. L. Whitfield: Molecular subsets in the gene expression signatures of scleroderma skin. PLoS ONE 3, e2696 (2008)
11. Y. S. Gu, J. Kong, G. S. Cheema, C. L. Keen, G. Wick and M. E. Gershwin: The immunobiology of systemic sclerosis. Semin Arthritis Rheum 38, 132-60 (2008)
12. B. White, W. C. Moore, F. M. Wigley, H. Q. Xiao and R. A. Wise: Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 132, 947-954 (2000) (Pubitemid 30397594)
13. V. D. Steen and T. A. Medsger Jr: Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41, 1613-1619 (1998) (Pubitemid 28459919)
14. V. K. Bournia, P. G. Vlachoyiannopoulos, C. Selmi, H. M. Moutsopoulos and M. E. Gershwin: Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 36, 176-200 (2009)
15. J. Avouac, J. Wipff, O. Goldman, B. Ruiz, P. O. Couraud, G. Chiocchia, A. Kahan, C. Boileau, G. Uzan and Y. Allanore: Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum 58, 3550-61 (2008)
16. J. Varga and B. Pasche: Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5, 200-6 (2009)
17. R. Domsic, K. Fasanella and K. Bielefeldt: Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci 53, 1163-74 (2008) (Pubitemid 351514626)
18. M. Sykes and B. Nikolic: Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435, 620-7 (2005) (Pubitemid 40825502)
19. J. M. Van Laar and A. Tyndall: Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 45, 1187-93 (2006) (Pubitemid 44542057)
20. Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C, et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum. 2005;52:1555-63. (Pubitemid 40663947)
21. D. Farge, C. Henegar, M. Carmagnat, M. Daneshpouy, Z. Marjanovic, C. Rabian, D. Ilie, C. Douay, N. Mounier, E. Clave, D. Bengoufa, J. Cabane, J. P. Marolleau, E. Gluckman, D. Charrona and A. Toubert: EBMT/EULAR Registry. Ann Rheum Dis 63, 974-981 (2004)
22. N. P. Nikolov and S. Z. Pavletic: Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease. Nat Clin Pract Rheumatol 4, 184-91 (2008)
23. J. M. van Laar, D. Farge and A. Tyndall: Autologous Stem Cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 64, 1515 (2005) (Pubitemid 41623870)
24. A. Tyndall and D. E. Furst: Adult stem cell treatment of scleroderma. Curr Opinion Rheumatol 19, 604-610 (2007) (Pubitemid 47530882)
25. J. M. van Laar, D. Farge and A. Tyndall: Stem cell transplantation: treatment option for severe systemic sclerosis? Ann Rheum Dis 67 suppl 3, iii 35-38 (2008)
26. P. Szodoray, L. Varoczy, G. Szegedi and M Zeher: Autologous stem cell transplantation in autoimmune diseases. Scand J Rheumatol (2009) (in press)
27. R. L. Edelson: Photopheresis: a new therapeutic concept. Yale J Biol Med 62, 565-77 (1989) (Pubitemid 20201938)
28. F. M. Moss: New insights into the mechanism of action of extracorporeal phototherapy. Transfusion 46, 6-8 (2006)
29. D. Peritt: Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12, 7-12 (2006) (Pubitemid 43034106)
30. E. Biagi, I. Di Biaso, V. Leoni, G. Gaipa, V. Rossi, C. Bugarin, G. Renoldi, M. Parma, A. Balduzzi, P. Perseghin and A. Biondi: Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 84, 31-9 (2007) (Pubitemid 47094638)
31. G. Gorgun, K. B. Miller and F. M. Foss: Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 100, 941-7 (2002) (Pubitemid 34832621)
32. J. Bladon and P. C. Taylor: Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 43, 85-94 (2006) (Pubitemid 44094006)
33. R. M. Knobler, L. E. French, Y. Kim, E. Bisaccia, W. Graninger, H. Nahavandi, F. J. Strobl, E. Keystone, M. Mehlmauer, A. H. Rook and I. Braverman; Systemic Sclerosis Study Group. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 54, 793-799 (2006)